These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24952689)

  • 1. Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy.
    Chatterjee NA; Upadhyay GA; Singal G; Parks KA; Dec GW; Singh JP; Lewis GD
    JACC Heart Fail; 2014 Jun; 2(3):230-7. PubMed ID: 24952689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
    J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy.
    Tedrow UB; Kramer DB; Stevenson LW; Stevenson WG; Baughman KL; Epstein LM; Lewis EF
    Am J Cardiol; 2006 Jun; 97(12):1737-40. PubMed ID: 16765124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of hyponatremia as a predictor for adverse events in patients with heart failure receiving cardiac resynchronization therapy.
    Sharma AK; Vegh EM; Kandala J; Orencole M; Januszkiewicz L; Bose A; Miller A; Parks KA; Heist EK; Singh JP
    Am J Cardiol; 2014 Jul; 114(1):83-7. PubMed ID: 24852916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling.
    Martens P; Verbrugge FH; Bertrand PB; Verhaert D; Vandervoort P; Dupont M; Tang WHW; Janssens S; Mullens W
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007813. PubMed ID: 30354673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical phenotype of adverse response to biventricular pacing: a case series.
    Lim HS
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):410-5. PubMed ID: 23305297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of right ventricular dysfunction after left ventricular assist device implantation.
    Nakatani S; Thomas JD; Savage RM; Vargo RL; Smedira NG; McCarthy PM
    Circulation; 1996 Nov; 94(9 Suppl):II216-21. PubMed ID: 8901749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between cardiac resynchronization response and pulmonary artery hemodynamic parameters.
    Li J; Qian Z; Qiu H; Jiang Z; Wang Y; Zhao H; Zhang H; Zhou Y; Hou X; Li X; Zou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):715-721. PubMed ID: 32879130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy.
    Campbell P; Takeuchi M; Bourgoun M; Shah A; Foster E; Brown MW; Goldenberg I; Huang DT; McNitt S; Hall WJ; Moss A; Pfeffer MA; Solomon SD;
    Circ Heart Fail; 2013 May; 6(3):435-42. PubMed ID: 23524528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.
    Rickenbacher PR; Trindade PT; Haywood GA; Vagelos RH; Schroeder JS; Willson K; Prikazsky L; Fowler MB
    J Am Coll Cardiol; 1996 Apr; 27(5):1192-7. PubMed ID: 8609341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular markers of mortality and ventricular arrhythmias in heart failure patients with cardiac resynchronization therapy.
    Hasselberg NE; Haugaa KH; Bernard A; Ribe MP; Kongsgaard E; Donal E; Edvardsen T
    Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):343-50. PubMed ID: 26164406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension due to left heart diseases.
    Vachiéry JL; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs JS; Martinez F; Semigran M; Simonneau G; Wells A; Seeger W
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D100-8. PubMed ID: 24355634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure.
    Shalaby A; Voigt A; El-Saed A; Saba S
    Am J Cardiol; 2008 Jan; 101(2):238-41. PubMed ID: 18178413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early right ventricular response to cardiac resynchronization therapy: impact on clinical outcomes.
    Stolfo D; Tonet E; Merlo M; Barbati G; Gigli M; Pinamonti B; Ramani F; Zecchin M; Sinagra G
    Eur J Heart Fail; 2016 Feb; 18(2):205-13. PubMed ID: 26635250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.